4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-23-021548
Chief Financial Officer acquired 66,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lee Sung · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-27 | Grant or award : show line 1 in the form | +66,500 | 66,500 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-27 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +133,000 | 133,000 | D |
Loading xslF345X04/doc4.xml…